Celadon Pharmaceuticals plc (CEL) ORD GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Celadon Pharmaceuticals finance chief to step down
30 September 2024 11:08
(Sharecast News) - Celadon Pharmaceuticals announced on Monday that Jonathan Turner, its chief financial officer, was stepping down.
-
Celadon inks partnership with Denmark's Valeos
11 September 2024 15:52
(Sharecast News) - Celadon Pharmaceuticals announced a strategic collaboration with Danish pharmaceutical company Valeos Pharma on Wednesday, to accelerate the production and supply of high-THC medical...
-
Celadon confident in seeing through funding challenges
23 August 2024 11:58
(Sharecast News) - Cannabis-based medicines specialist Celadon Pharmaceuticals updated the market on its financial position on Friday, amid ongoing challenges related to delays in expected funding.
-
Celadon Pharmaceuticals raises £2.1m for working capital
10 May 2024 11:48
(Sharecast News) - Medical cannabis specialist Celadon Pharmaceuticals announced on Friday that it has raised £2.1m to provide it with additional working capital.
-
Celadon starts supplying cannabis for two contracts
14 December 2023 11:16
(Sharecast News) - Medical cannabis specialist Celadon Pharmaceuticals has started supplying its pharmaceutical-grade product to two commercial contracts, first announced on 24 May and 5 September, it said...
-
Celadon's new finance chief to join later in January
13 January 2023 13:24
(Sharecast News) - Celadon Pharmaceuticals updated the market on the arrival of its new finance chief on Friday.
-
Celadon confident in approval for its cannabis medicine facility
22 December 2022 14:50
(Sharecast News) - Cannabis-based medicine developer Celadon Pharmaceuticals updated the market on its application for registration of its West Midlands facility with the UK Medicines and Healthcare products...
Company announcements Announcements
-
Update on Financial Position
18 November 2024 07:00
Celadon Pharmaceuticals
-
New Sales Contract with a Healthcare Company
2 October 2024 07:00
Celadon Pharmaceuticals
-
Departure of Chief Financial Officer
30 September 2024 07:05
Celadon Pharmaceuticals
-
Interim Results
30 September 2024 07:00
Celadon Pharmaceuticals
-
Admission of Shares and Total Voting Rights
17 September 2024 09:28
Celadon Pharmaceuticals
-
Equity Fundraise and Update on Financial Position
11 September 2024 07:05
Celadon Pharmaceuticals
-
Strategic collaboration with Valeos
11 September 2024 07:00
Celadon Pharmaceuticals
-
Update on Financial Position
23 August 2024 07:00
Celadon Pharmaceuticals
-
Update on Operations and Financial Position
12 August 2024 07:00
Celadon Pharmaceuticals
-
Successful Completion of Eighth Harvest of 2024
16 July 2024 07:00
Celadon Pharmaceuticals
-
Third Admission of Shares
15 July 2024 13:58
Celadon Pharmaceuticals
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.